PMC:7784828 / 7803-8487 JSONTXT

{"project":"LitCovid-sentences","denotations":[{"id":"T74","span":{"begin":0,"end":6},"obj":"Sentence"},{"id":"T75","span":{"begin":8,"end":21},"obj":"Sentence"},{"id":"T76","span":{"begin":22,"end":145},"obj":"Sentence"},{"id":"T77","span":{"begin":146,"end":284},"obj":"Sentence"},{"id":"T78","span":{"begin":285,"end":353},"obj":"Sentence"},{"id":"T79","span":{"begin":354,"end":516},"obj":"Sentence"},{"id":"T80","span":{"begin":517,"end":684},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"2.1.4. Rare diseases\nAlthough individual occurrence is rare, collectively rare diseases is a problem affecting 6–8% of the world population [7]. The Rare Diseases Clinical Research Network was established by The National Institutes of Health (NIH) to address these unique challenges. Among the 7,000 rare diseases, treatments are available only for 5%. Altogether across the globe, there are 350 million people diagnosed with rare diseases and half of them are children, a third of which are below 5-years old [22]. There is a great disparity in access to orphan medicinal products (OMPs) and healthcare services among world countries despite mounting international initiatives [23]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"120","span":{"begin":405,"end":411},"obj":"Species"},{"id":"121","span":{"begin":462,"end":470},"obj":"Species"}],"attributes":[{"id":"A120","pred":"tao:has_database_id","subj":"120","obj":"Tax:9606"},{"id":"A121","pred":"tao:has_database_id","subj":"121","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"2.1.4. Rare diseases\nAlthough individual occurrence is rare, collectively rare diseases is a problem affecting 6–8% of the world population [7]. The Rare Diseases Clinical Research Network was established by The National Institutes of Health (NIH) to address these unique challenges. Among the 7,000 rare diseases, treatments are available only for 5%. Altogether across the globe, there are 350 million people diagnosed with rare diseases and half of them are children, a third of which are below 5-years old [22]. There is a great disparity in access to orphan medicinal products (OMPs) and healthcare services among world countries despite mounting international initiatives [23]."}